We proudly celebrate our 23rd birthday, celebrating innovation, collaboration and scientific excellence that Pharmidex has helped create!
May 19, 2025
Since 2002,
Pharmidex has grown into a trusted partner in preclinical drug discovery and development, contributing to over 16,000 studies across therapeutic areas including CNS, immunology, oncology, respiratory and stroke.
We’re proud to be AAALAC- and MHRA-accredited, providing high-quality GLP and GCP-compliant services that have supported clients across biotech, pharma, and academia worldwide.
Our integrated expertise in Clinical Pathology, DMPK, ADMET, Pharmacokinetics, Toxicology and BBB penetration studies continues to shape the success of early-stage drug candidates.
π‘ As we commemorate this milestone, we reflect on:
β The dedication of our exceptional team
β The trust and collaboration of our partners and clients
β Our continued mission to advance science and improve lives
Here’s to 23 years of impact and many more to come!

#Pharmidex23 #DrugDiscovery #PharmaceuticalInnovation #CRO #DMPK #OncologyResearch #CNS #PreclinicalResearch #TeamPharmidex

Join our Bioanalysis Group to advance drug discovery! π¬ Role: - LC-MS/MS analysis in biological matrices - Method development/validation - Sample prep & study support - Ensure data quality π‘ You need: - BSc/MSc (Chemistry/Biochemistry) - LC-MS/MS experience - GLP/GCP knowledge - Problem-solving skills π We offer: - Competitive salary + pension - Training & growth - Life insurance, perks, parking π§ Apply: CV to [email protected]

At Pharmidex , we go beyond exceptional science we deliver an experience built on trust, flexibility and deep collaboration. π Scientist-Led from Start to Finish Your journey begins and ends with scientists, not sales teams. Our BD and Ops leads bring real scientific expertise to every conversation, ensuring smart, tailored study design and seamless execution. π€ Connected Teams, Coordinated Delivery From DMPK and bioanalysis to in vivo pharmacology, our integrated teams ensure smooth handoffs, eliminating delays and duplication. π§ͺ Agile, High-Quality Science We adapt to evolving study needs across CNS, oncology, respiratory, autoimmune and rare diseases without compromising on quality. GLP and non-GLP studies are delivered on time, with transparency. π§ We’re Not Just a CRO, We’re Your Partner We offer guidance on model selection, regulatory strategy, data interpretation, and more. Your success is our mission. Let’s partner on your next breakthrough. π§ Contact us today.